Savient Pharmaceuticals (SVNT) Tops Q1 Per Share Views
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Join SI Premium – FREE
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q1 loss of ($0.19), $0.12 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $1.29 million versus the consensus estimate of $2.09 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03
- Hyperion DeFi (HYPD) Tops Q2 EPS by 57c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
